Ronald W. Falcon, M.D.
Dr. Ronald Falcon, M.D., is an expert in gay men’s health and HIV treatment strategies. He has a broad range of clinical and pharmaceutical experience, and currently serves as the Vice President of Clinical Affairs at Tibotec Therapeutics, a Johnson & Johnson Company that develops medications for HIV, Hepatitis, Tuberculosis and other infectious diseases.
Ron serves as national co-chair of the GLBT Affinity Group known as GLOBAL (the Gay & Lesbian Organization for Business And Leadership) at Johnson & Johnson. In this role, he brings GLBT topics to the forefront, championing a number of initiatives aligned to the businesses and the Johnson & Johnson Credo.
A board-certified Family Physician and an accomplished speaker and educator, he received his M.D. from Temple University School of Medicine in Philadelphia, Pennsylvania, and completed a residency and an HIV preceptorship at Regions Hospital in St. Paul, MN. From September 2001 to May 2002, Dr. Falcon was a Policy Fellow at the Hubert H. Humphrey Institute of Public Affairs, University of Minnesota. He has served on the board of directors for the Gay and Lesbian Medical Association and founded the not for profit Rainbow Health Initiative which seeks to improve the health of GLBT people in Minnesota.
Previously, as a provider of primary and HIV care, Dr. Falcon served as Director of Primary Care at Regions Hospital HIV Clinic and Director of the HIV Treatment and Research Center at the Minnesota Comprehensive Care Center, where he collaborated on the preclinical development of antiretroviral therapy. Ron has lead several clinical trials in HIV, published numerous abstracts and articles and has presented CME lectures and conferences on GLBT health and the clinical aspects of HIV/AIDS and HIV therapy.
Ron and his partner Chad celebrated their 10 year anniversary by having a civil union ceremony in New Jersey with family, friends and co-workers. They are the proud parents of twin boys and two Portuguese Water Dogs.